AR034278A1 - Compuestos de 4-amino-azepan-3-ona 1-amino-1-acil cicloalcano c3-6 sustituidos, composiciones farmaceuticas que los comprenden, intermediarios, procedimiento para la sintesis de dichos compuestos, y el uso de dichos compuestos en la fabricacion de medicamentos - Google Patents
Compuestos de 4-amino-azepan-3-ona 1-amino-1-acil cicloalcano c3-6 sustituidos, composiciones farmaceuticas que los comprenden, intermediarios, procedimiento para la sintesis de dichos compuestos, y el uso de dichos compuestos en la fabricacion de medicamentosInfo
- Publication number
- AR034278A1 AR034278A1 ARP010105409A ARP010105409A AR034278A1 AR 034278 A1 AR034278 A1 AR 034278A1 AR P010105409 A ARP010105409 A AR P010105409A AR P010105409 A ARP010105409 A AR P010105409A AR 034278 A1 AR034278 A1 AR 034278A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- het
- compounds
- cycloalkyl
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25250800P | 2000-11-22 | 2000-11-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR034278A1 true AR034278A1 (es) | 2004-02-18 |
Family
ID=22956303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010105409A AR034278A1 (es) | 2000-11-22 | 2001-11-20 | Compuestos de 4-amino-azepan-3-ona 1-amino-1-acil cicloalcano c3-6 sustituidos, composiciones farmaceuticas que los comprenden, intermediarios, procedimiento para la sintesis de dichos compuestos, y el uso de dichos compuestos en la fabricacion de medicamentos |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1392657A4 (fr) |
JP (1) | JP2005513083A (fr) |
KR (1) | KR20040004445A (fr) |
CN (1) | CN1635903A (fr) |
AR (1) | AR034278A1 (fr) |
AU (1) | AU2001298052A1 (fr) |
BR (1) | BR0115473A (fr) |
CA (1) | CA2436850A1 (fr) |
CZ (1) | CZ20031403A3 (fr) |
HU (1) | HUP0301964A3 (fr) |
IL (1) | IL155997A0 (fr) |
MX (1) | MXPA03004542A (fr) |
NO (1) | NO20032328L (fr) |
PL (1) | PL366232A1 (fr) |
UY (1) | UY27032A1 (fr) |
WO (1) | WO2003053331A2 (fr) |
ZA (1) | ZA200303848B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
JP2003527429A (ja) | 2000-03-21 | 2003-09-16 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害物質 |
BR0111693A (pt) * | 2000-06-14 | 2004-04-06 | Smithkline Beecham Corp | Inibidores de protease |
WO2008149971A1 (fr) | 2007-06-08 | 2008-12-11 | Kyoto University | Agent thérapeutique ou prophylactique contre l'anévrisme cérébral |
EP2216047A4 (fr) | 2007-10-24 | 2011-12-28 | Nat Univ Corp Tokyo Med & Dent | Régulateur pour la signalisation du récepteur toll-like, comportant un inhibiteur de la cathepsine comme principe actif |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000038687A1 (fr) * | 1998-12-23 | 2000-07-06 | Smithkline Beecham Corporation | Inhibiteurs de proteases |
JP2003527429A (ja) * | 2000-03-21 | 2003-09-16 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害物質 |
BR0111693A (pt) * | 2000-06-14 | 2004-04-06 | Smithkline Beecham Corp | Inibidores de protease |
-
2001
- 2001-11-19 JP JP2003554091A patent/JP2005513083A/ja not_active Withdrawn
- 2001-11-19 KR KR10-2003-7006807A patent/KR20040004445A/ko not_active Application Discontinuation
- 2001-11-19 BR BR0115473-7A patent/BR0115473A/pt not_active Application Discontinuation
- 2001-11-19 CZ CZ20031403A patent/CZ20031403A3/cs unknown
- 2001-11-19 PL PL01366232A patent/PL366232A1/xx not_active Application Discontinuation
- 2001-11-19 HU HU0301964A patent/HUP0301964A3/hu unknown
- 2001-11-19 EP EP01275089A patent/EP1392657A4/fr not_active Withdrawn
- 2001-11-19 MX MXPA03004542A patent/MXPA03004542A/es unknown
- 2001-11-19 AU AU2001298052A patent/AU2001298052A1/en not_active Abandoned
- 2001-11-19 WO PCT/US2001/051647 patent/WO2003053331A2/fr not_active Application Discontinuation
- 2001-11-19 CN CNA018220533A patent/CN1635903A/zh active Pending
- 2001-11-19 IL IL15599701A patent/IL155997A0/xx unknown
- 2001-11-19 CA CA002436850A patent/CA2436850A1/fr not_active Abandoned
- 2001-11-20 AR ARP010105409A patent/AR034278A1/es unknown
- 2001-11-21 UY UY27032A patent/UY27032A1/es not_active Application Discontinuation
-
2003
- 2003-05-16 ZA ZA200303848A patent/ZA200303848B/en unknown
- 2003-05-22 NO NO20032328A patent/NO20032328L/no unknown
Also Published As
Publication number | Publication date |
---|---|
JP2005513083A (ja) | 2005-05-12 |
PL366232A1 (en) | 2005-01-24 |
CN1635903A (zh) | 2005-07-06 |
UY27032A1 (es) | 2002-07-31 |
HUP0301964A2 (en) | 2007-02-28 |
EP1392657A2 (fr) | 2004-03-03 |
ZA200303848B (en) | 2004-06-28 |
AU2001298052A1 (en) | 2003-07-09 |
BR0115473A (pt) | 2004-09-28 |
HUP0301964A3 (en) | 2007-09-28 |
CA2436850A1 (fr) | 2003-07-03 |
WO2003053331A3 (fr) | 2003-11-13 |
IL155997A0 (en) | 2003-12-23 |
WO2003053331A2 (fr) | 2003-07-03 |
KR20040004445A (ko) | 2004-01-13 |
CZ20031403A3 (cs) | 2003-10-15 |
NO20032328D0 (no) | 2003-05-22 |
MXPA03004542A (es) | 2003-09-10 |
NO20032328L (no) | 2003-07-02 |
EP1392657A4 (fr) | 2004-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR032877A1 (es) | Inhibidores alquil c(1-6)-4-amino-azepan-3-onicos de proteasas, composiciones farmaceuticas que los comprenden, intermediarios utiles en la preparacion de tales compuestos, procedimiento para la sintesis de dichos inhibidores, y uso de dichos inhibidores en la fabricacion de medicamentos | |
SE0203754D0 (sv) | New compounds | |
ES2195034T3 (es) | Inhibidor de metaloproteinasas, composicion farmaceutica que contiene este inhibidor y su utilizacion farmaceutica, y procedimientos que sirven para su preparacion. | |
CY1108894T1 (el) | Νεα παραγωγα βενζιμιδαζολης | |
UY24660A1 (es) | Procedimiento para preparar inhibidores de cisteina proteasas | |
AR035320A1 (es) | Compuestos activadores de hppardelta, composicion farmaceutica, su uso en la preparacion de medicamentos, metodo para el tratamiento de enfermedades mediadas por hppardelta | |
AR034268A1 (es) | Compuestos derivados de piperidina, su uso en preparacion de medicamentos, composicion farmaceutica, metodo de tratamiento y proceso para su preparacion | |
ES2181153T3 (es) | Compuestos de triazinilaminoestilbeno. | |
CO4700421A1 (es) | Compuestos de naftilo, intermedios, composiciones y procedimientos | |
UY27700A1 (es) | Compuestos oxo - azabiclícos. | |
BRPI0406717A (pt) | Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção | |
FI970317A0 (fi) | Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä | |
AR018139A1 (es) | Un compuesto n-[3-hidroxi-5[(1,4,5,6-tetrahidro-5-hidroxi-2-pirimidinil)amino]benzoil]glici-3-(3-halo-5-halo-2-hidroxifenil)-beta alanina, composicionfarmaceutica y uso del mismo en la fabricacion de un medicamento. | |
UY25143A1 (es) | Procedimiento para la preparacion de inhibidores de proteasas. | |
AR038818A1 (es) | Compuesto de piperidina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion | |
SE0403171D0 (sv) | New compounds | |
CO5550439A2 (es) | Compuestos derivados de arilsulfonil-piperazina que tienen afinidad al receptor 5-ht6 y composiciones farmaceuticas que los contienen | |
AR039651A1 (es) | Derivados de isoquinolina | |
AR040253A1 (es) | Fluorobenzamidas, procesos de preparacion y medicamento | |
AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
AR032622A1 (es) | Compuestos de 4-amino-azepan-3-ona, composiciones farmaceuticas que los comprenden, intermediarios utiles en la sintesis de tales compuestos, procedimiento para la sintesis de dichos compuestos, y uso de tales compuestos en la fabricacion de medicamentos | |
AR034278A1 (es) | Compuestos de 4-amino-azepan-3-ona 1-amino-1-acil cicloalcano c3-6 sustituidos, composiciones farmaceuticas que los comprenden, intermediarios, procedimiento para la sintesis de dichos compuestos, y el uso de dichos compuestos en la fabricacion de medicamentos | |
MXPA04005313A (es) | Derivados de aminotetralin como antagonistas del receptor muscarinico. | |
AR018867A1 (es) | Composicion farmaceutica, uso de la composicion, estuche, uso de los compuestos para preparar la composicion y el estuche | |
UY26666A1 (es) | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |